NCT02538211View on ClinicalTrials.gov

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

February 28, 2017

Conditions
Rotavirus InfectionsIntestinal Bacteria Flora DisturbanceReaction - Vaccine NosTetanusStreptococcal Pneumonia
Interventions
BIOLOGICAL

Rotavirus vaccine, Tetanus vaccine and Pneumococcal vaccine

All subjects will be given an oral dose of the rotavirus vaccine, RotarixTM, and intramuscular injections of the Tetanus vaccine and Pneumococcal vaccine, Pneumo 23.

Trial Locations (1)

1105 AZ

Academic Medical Center, Amsterdam

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Wageningen University and Research

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT02538211 - The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses | Biotech Hunter | Biotech Hunter